The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on social media and around dinner tables.

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

The Navitus survey also found that nearly 60% of users are aware of safety concerns tied to compounded GLP-1 products. More ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

ATFW Explores 2026 Fitness Industry Trends, GLP-1 Coaching Shifts, and Global Growth at HFA Show. As the fitness and wellness ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...